Concepedia

Gijs van de Wetering

GV

7

Publications

110

Citations

7

H-Index

2011

Active since

Affiliations

Radboud University Medical Center(Current)

AbbVie (United States)

Pharmerit (Netherlands)

Radboud University Nijmegen

Dana-Farber Cancer Institute

Gijs van de Wetering is an author at Radboud University Medical Center specializing in health economics, economic analysis, and public health.

ORCID

Top concepts

Publications per year

2011–2022

7

Publications

7

The CareWell-primary care program: design of a cluster controlled trial and process evaluation of a complex intervention targeting community-dwelling frail elderly

Franca G.H. Ruikes, Antoinette RM Meys, Gijs van de Wetering et al. · BMC Family Practice · 2012 · 25 citations · Full text

Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States

Anuja Chatterjee, Sheila Shapouri, Beenish S. Manzoor et al. · Journal of Managed Care & Specialty Pharmacy · 2021 · 19 citations · Full text

Cost-effectiveness analysis of anti–IL-5 therapies of severe eosinophilic asthma in Spain

Francisco Javier González‐Barcala, Xavier Muñoz, Esther Mariscal et al. · Journal of Medical Economics · 2021 · 16 citations · Full text

A model to correct for short‐run inefficiencies in economic evaluations in healthcare

Gijs van de Wetering, Willem Woertman, Eddy Adang · Health Economics · 2011 · 15 citations

, , +25

Biologic treatment sequences for plaque psoriasis: a cost-utility analysis based on 10 years of Dutch real-world evidence from BioCAPTURE

S. Klijn, J. M. P. A. van den Reek, Gijs van de Wetering et al. · British Journal of Dermatology · 2017 · 12 citations

Rows per page

1–5 of 7